IPI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IPI is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants to enter now. The stock has no strong bullish proprietary signal, no recent news catalyst, and analyst coverage remains negative with a Sell rating. While options sentiment is somewhat bullish and the stock may have short-term bounce potential, the current technical setup is still weak enough that I would not call this a clear buy today.
Current price is 34.34 in pre-market, essentially flat at -0.06%. Trend indicators are mixed to weak: MACD histogram is -0.59 and below zero, though it is negatively contracting, which suggests downside momentum is slowing. RSI_6 at 26.96 is near oversold territory, but not yet a strong reversal confirmation. Moving averages are converging, indicating compression rather than a clear uptrend. Price is below the pivot at 36.654 and only slightly above S1 at 33.915, so the stock is trading near support rather than in a confirmed breakout phase. Overall, the chart is not strong enough for a decisive long-term entry right now.
["Options sentiment is bullish, with low put-call ratios and higher call activity.", "RSI is close to oversold, which can support a short-term rebound.", "Similar candlestick pattern analysis suggests positive upside probabilities over the next day, week, and month.", "Pre-market price is stable, showing no immediate breakdown."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "UBS kept a Sell rating and raised the target only slightly to $26, which is still far below the current price.", "No significant hedge fund or insider buying trend.", "No recent congress trading activity.", "MACD remains negative and moving averages are only converging, not confirming an uptrend."]
No usable latest-quarter financial snapshot was provided due to an error, so I cannot confirm revenue or earnings growth from the most recent quarter season. Based on the available dataset, there is no financial update supporting a new long-term buy case.
Recent analyst trend is weak: UBS on 2026-05-14 raised the price target to $26 from $25 but maintained a Sell rating. That means the Street view remains bearish overall, even after a minor target increase. Wall Street pros appear to see limited upside and more downside risk from the current level, which is a negative for a beginner long-term buyer.
